GlaxoSmithKline Biologicals S.A.
PolandAll drugs from this manufacturer
-
The vaccine is used to prevent diphtheria, tetanus, and pertussis (whooping cough). It helps the body develop its own immunity to these three diseases.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided ATC: J07AJ52
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It helps the body develop immunity to these four diseases.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid > or equal to 2 IU (2.5 Lf) aluminum phosphate 0.2 mg Al 3+ inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D tetanus toxoid > or equal 20 IU (5 Lf) aluminum hydroxide hydrate 0.3 mg Al 3+ bordetella pertussis antigens 8 mcg + 8 mcg + 2.5 mcg ATC: J07CA02
-
The vaccine is used to prevent hepatitis B virus (HBV).
Dosage form: suspension for injection
Active substance Dosage hepatitis b surface antigen hbsag 20 mcg/ml ATC: J07BC01
-
The vaccine is used to prevent hepatitis B virus (HBV) infection. It helps the body develop its own immunity by producing antibodies against this virus.
Dosage form: suspension for injection
Active substance Dosage hepatitis b surface antigen hbsag 10 mcg/0.5 ml ATC: J07BC01
-
It is used to prevent hepatitis A (HAV) in individuals from 1 year of age up to and including 15 years, and if necessary, also in adolescents aged 16 to 18 years.
Dosage form: suspension for injection
Active substance Dosage hepatitis a virus, strain hm175 inactivated not less than 720 ELISA units ATC: J07BC02
-
It is used to prevent hepatitis A (HAV) in individuals over 16 years of age who are at risk of infection with this virus.
Dosage form: suspension for injection
Active substance Dosage hepatitis a virus, strain hm175 inactivated not less than 1440 ELISA units ATC: J07BC02
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), poliomyelitis (polio), and infections caused by Haemophilus influenzae type b (Hib) in children.
Dosage form: powder and suspension for preparation of injection suspension
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided inactivated poliovirus types 1, 2 and 3 No input provided haemophilus b polysaccharide conjugated with tetanus toxoid No input provided ATC: J07CA06
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio).
Dosage form: suspension for injection
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D diphtheria toxoid or equal to 30 IU tetanus toxoid or equal to 40 IU pertussis antigens 25 mcg + 25 mcg + 8 mcg ATC: J07CA02
-
It is used in children over 9 months of age, adolescents, and adults to prevent measles, mumps, and rubella.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage live attenuated measles virus strain schwarz not less than 10^3.0 CCID50 live attenuated mumps virus (rit 4385 strain derived from jeryl lynn strain) not less than 10^3.7 CCID50 live attenuated rubella virus wistar ra 27/3 strain not less than 10^3.0 CCID50 ATC: J07BD52
-
It is used to prevent diseases caused by the measles, mumps, rubella, and varicella (chickenpox) viruses.
Dosage form: solution for injection, powder and solvent for preparation of solution for injection in prefilled syringe
Active substance Dosage measles mumps rubella and varicella vaccine live No input provided ATC: J07BD54
-
The vaccine is used to prevent diseases caused by the measles, mumps, rubella, and varicella viruses.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage measles mumps rubella and varicella vaccine live No input provided ATC: J07BD54
-
The vaccine is used to prevent chickenpox. Vaccination within 3 days of contact with an infected person may help prevent the disease or reduce its severity.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage varicella zoster virus oka strain not less than 2000 PFU ATC: J07BK01